REPORT ID 2789

Asia-Pacific Cardiac Biomarkers Market Report 2017

Publish Date
11-Dec-17
Pages
101
Format
Electronic (PDF)

In this report, the Asia-Pacific Cardiac Biomarkers market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split Asia-Pacific into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Cardiac Biomarkers for these regions, from 2012 to 2022 (forecast), including
    China
    Japan
    South Korea
    Taiwan
    India
    Southeast Asia
    Australia

Asia-Pacific Cardiac Biomarkers market competition by top manufacturers/players, with Cardiac Biomarkers sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
    Abbott Laboratories
    Alere
    Siemens Healthcare GmbH
    Roche Diagnostics Corporation
    Beckman Coulter, Inc.
    BG Medicines
    Thermo Fisher Scientific, Inc.
    BioMerieux SA
    Bio-Rad Laboratories

On the basis of product, this report displays the sales volum, revenue, product price, market share and growth rate of each type, primarily split into
    Troponin
    LDH isoenzymes
    Myoglobin
    Ischemia Modified Albumin (IMA)
    Heart-type Fatty Acid Binding Protein (H-FABP)

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Acute Coronary Syndrome
    Myocardial Infarction
    Congestive Heart Failure
    Cardiomyopathy
    Ischemia
    Myocarditis
    Atrial Fibrillation

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

Asia-Pacific Cardiac Biomarkers Market Report 2017
1 Cardiac Biomarkers Overview
    1.1 Product Overview and Scope of Cardiac Biomarkers
    1.2 Classification of Cardiac Biomarkers by Product Category
        1.2.1 Asia-Pacific Cardiac Biomarkers Market Size (Sales) Comparison by Types (2012-2022)
        1.2.2 Asia-Pacific Cardiac Biomarkers Market Size (Sales) Market Share by Type (Product Category) in 2016
        1.2.3 Troponin
        1.2.4 LDH isoenzymes
        1.2.5 Myoglobin
        1.2.6 Ischemia Modified Albumin (IMA)
        1.2.7 Heart-type Fatty Acid Binding Protein (H-FABP)
    1.3 Asia-Pacific Cardiac Biomarkers Market by Application/End Users
        1.3.1 Asia-Pacific Cardiac Biomarkers Sales (Volume) and Market Share Comparison by Applications (2012-2022)
        1.3.2 Acute Coronary Syndrome
        1.3.3 Myocardial Infarction
        1.3.4 Congestive Heart Failure
        1.3.5 Cardiomyopathy
        1.3.6 Ischemia
        1.3.7 Myocarditis
        1.3.8 Atrial Fibrillation
    1.4 Asia-Pacific Cardiac Biomarkers Market by Region
        1.4.1 Asia-Pacific Cardiac Biomarkers Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 China Status and Prospect (2012-2022)
        1.4.3 Japan Status and Prospect (2012-2022)
        1.4.4 South Korea Status and Prospect (2012-2022)
        1.4.5 Taiwan Status and Prospect (2012-2022)
        1.4.6 India Status and Prospect (2012-2022)
        1.4.7 Southeast Asia Status and Prospect (2012-2022)
        1.4.8 Australia Status and Prospect (2012-2022)
    1.5 Asia-Pacific Market Size (Value and Volume) of Cardiac Biomarkers (2012-2022)
        1.5.1 Asia-Pacific Cardiac Biomarkers Sales and Growth Rate (2012-2022)
        1.5.2 Asia-Pacific Cardiac Biomarkers Revenue and Growth Rate (2012-2022)

2 Asia-Pacific Cardiac Biomarkers Competition by Players/Suppliers, Region, Type and Application
    2.1 Asia-Pacific Cardiac Biomarkers Market Competition by Players/Suppliers
        2.1.1 Asia-Pacific Cardiac Biomarkers Sales Volume and Market Share of Key Players/Suppliers (2012-2017)
        2.1.2 Asia-Pacific Cardiac Biomarkers Revenue and Share by Players/Suppliers (2012-2017)
    2.2 Asia-Pacific Cardiac Biomarkers (Volume and Value) by Type
        2.2.1 Asia-Pacific Cardiac Biomarkers Sales and Market Share by Type (2012-2017)
        2.2.2 Asia-Pacific Cardiac Biomarkers Revenue and Market Share by Type (2012-2017)
    2.3 Asia-Pacific Cardiac Biomarkers (Volume) by Application
    2.4 Asia-Pacific Cardiac Biomarkers (Volume and Value) by Region
        2.4.1 Asia-Pacific Cardiac Biomarkers Sales and Market Share by Region (2012-2017)
        2.4.2 Asia-Pacific Cardiac Biomarkers Revenue and Market Share by Region (2012-2017)

3 China Cardiac Biomarkers (Volume, Value and Sales Price)
    3.1 China Cardiac Biomarkers Sales and Value (2012-2017)
        3.1.1 China Cardiac Biomarkers Sales Volume and Growth Rate (2012-2017)
        3.1.2 China Cardiac Biomarkers Revenue and Growth Rate (2012-2017)
        3.1.3 China Cardiac Biomarkers Sales Price Trend (2012-2017)
    3.2 China Cardiac Biomarkers Sales Volume and Market Share by Type
    3.3 China Cardiac Biomarkers Sales Volume and Market Share by Application

4 Japan Cardiac Biomarkers (Volume, Value and Sales Price)
    4.1 Japan Cardiac Biomarkers Sales and Value (2012-2017)
        4.1.1 Japan Cardiac Biomarkers Sales Volume and Growth Rate (2012-2017)
        4.1.2 Japan Cardiac Biomarkers Revenue and Growth Rate (2012-2017)
        4.1.3 Japan Cardiac Biomarkers Sales Price Trend (2012-2017)
    4.2 Japan Cardiac Biomarkers Sales Volume and Market Share by Type
    4.3 Japan Cardiac Biomarkers Sales Volume and Market Share by Application

5 South Korea Cardiac Biomarkers (Volume, Value and Sales Price)
    5.1 South Korea Cardiac Biomarkers Sales and Value (2012-2017)
        5.1.1 South Korea Cardiac Biomarkers Sales Volume and Growth Rate (2012-2017)
        5.1.2 South Korea Cardiac Biomarkers Revenue and Growth Rate (2012-2017)
        5.1.3 South Korea Cardiac Biomarkers Sales Price Trend (2012-2017)
    5.2 South Korea Cardiac Biomarkers Sales Volume and Market Share by Type
    5.3 South Korea Cardiac Biomarkers Sales Volume and Market Share by Application

6 Taiwan Cardiac Biomarkers (Volume, Value and Sales Price)
    6.1 Taiwan Cardiac Biomarkers Sales and Value (2012-2017)
        6.1.1 Taiwan Cardiac Biomarkers Sales Volume and Growth Rate (2012-2017)
        6.1.2 Taiwan Cardiac Biomarkers Revenue and Growth Rate (2012-2017)
        6.1.3 Taiwan Cardiac Biomarkers Sales Price Trend (2012-2017)
    6.2 Taiwan Cardiac Biomarkers Sales Volume and Market Share by Type
    6.3 Taiwan Cardiac Biomarkers Sales Volume and Market Share by Application

7 India Cardiac Biomarkers (Volume, Value and Sales Price)
    7.1 India Cardiac Biomarkers Sales and Value (2012-2017)
        7.1.1 India Cardiac Biomarkers Sales Volume and Growth Rate (2012-2017)
        7.1.2 India Cardiac Biomarkers Revenue and Growth Rate (2012-2017)
        7.1.3 India Cardiac Biomarkers Sales Price Trend (2012-2017)
    7.2 India Cardiac Biomarkers Sales Volume and Market Share by Type
    7.3 India Cardiac Biomarkers Sales Volume and Market Share by Application

8 Southeast Asia Cardiac Biomarkers (Volume, Value and Sales Price)
    8.1 Southeast Asia Cardiac Biomarkers Sales and Value (2012-2017)
        8.1.1 Southeast Asia Cardiac Biomarkers Sales Volume and Growth Rate (2012-2017)
        8.1.2 Southeast Asia Cardiac Biomarkers Revenue and Growth Rate (2012-2017)
        8.1.3 Southeast Asia Cardiac Biomarkers Sales Price Trend (2012-2017)
    8.2 Southeast Asia Cardiac Biomarkers Sales Volume and Market Share by Type
    8.3 Southeast Asia Cardiac Biomarkers Sales Volume and Market Share by Application

9 Australia Cardiac Biomarkers (Volume, Value and Sales Price)
    9.1 Australia Cardiac Biomarkers Sales and Value (2012-2017)
        9.1.1 Australia Cardiac Biomarkers Sales Volume and Growth Rate (2012-2017)
        9.1.2 Australia Cardiac Biomarkers Revenue and Growth Rate (2012-2017)
        9.1.3 Australia Cardiac Biomarkers Sales Price Trend (2012-2017)
    9.2 Australia Cardiac Biomarkers Sales Volume and Market Share by Type
    9.3 Australia Cardiac Biomarkers Sales Volume and Market Share by Application

10 Asia-Pacific Cardiac Biomarkers Players/Suppliers Profiles and Sales Data
    10.1 Abbott Laboratories
        10.1.1 Company Basic Information, Manufacturing Base and Competitors
        10.1.2 Cardiac Biomarkers Product Category, Application and Specification
            10.1.2.1 Product A
            10.1.2.2 Product B
        10.1.3 Abbott Laboratories Cardiac Biomarkers Sales, Revenue, Price and Gross Margin (2012-2017)
        10.1.4 Main Business/Business Overview
    10.2 Alere
        10.2.1 Company Basic Information, Manufacturing Base and Competitors
        10.2.2 Cardiac Biomarkers Product Category, Application and Specification
            10.2.2.1 Product A
            10.2.2.2 Product B
        10.2.3 Alere Cardiac Biomarkers Sales, Revenue, Price and Gross Margin (2012-2017)
        10.2.4 Main Business/Business Overview
    10.3 Siemens Healthcare GmbH
        10.3.1 Company Basic Information, Manufacturing Base and Competitors
        10.3.2 Cardiac Biomarkers Product Category, Application and Specification
            10.3.2.1 Product A
            10.3.2.2 Product B
        10.3.3 Siemens Healthcare GmbH Cardiac Biomarkers Sales, Revenue, Price and Gross Margin (2012-2017)
        10.3.4 Main Business/Business Overview
    10.4 Roche Diagnostics Corporation
        10.4.1 Company Basic Information, Manufacturing Base and Competitors
        10.4.2 Cardiac Biomarkers Product Category, Application and Specification
            10.4.2.1 Product A
            10.4.2.2 Product B
        10.4.3 Roche Diagnostics Corporation Cardiac Biomarkers Sales, Revenue, Price and Gross Margin (2012-2017)
        10.4.4 Main Business/Business Overview
    10.5 Beckman Coulter, Inc.
        10.5.1 Company Basic Information, Manufacturing Base and Competitors
        10.5.2 Cardiac Biomarkers Product Category, Application and Specification
            10.5.2.1 Product A
            10.5.2.2 Product B
        10.5.3 Beckman Coulter, Inc. Cardiac Biomarkers Sales, Revenue, Price and Gross Margin (2012-2017)
        10.5.4 Main Business/Business Overview
    10.6 BG Medicines
        10.6.1 Company Basic Information, Manufacturing Base and Competitors
        10.6.2 Cardiac Biomarkers Product Category, Application and Specification
            10.6.2.1 Product A
            10.6.2.2 Product B
        10.6.3 BG Medicines Cardiac Biomarkers Sales, Revenue, Price and Gross Margin (2012-2017)
        10.6.4 Main Business/Business Overview
    10.7 Thermo Fisher Scientific, Inc.
        10.7.1 Company Basic Information, Manufacturing Base and Competitors
        10.7.2 Cardiac Biomarkers Product Category, Application and Specification
            10.7.2.1 Product A
            10.7.2.2 Product B
        10.7.3 Thermo Fisher Scientific, Inc. Cardiac Biomarkers Sales, Revenue, Price and Gross Margin (2012-2017)
        10.7.4 Main Business/Business Overview
    10.8 BioMerieux SA
        10.8.1 Company Basic Information, Manufacturing Base and Competitors
        10.8.2 Cardiac Biomarkers Product Category, Application and Specification
            10.8.2.1 Product A
            10.8.2.2 Product B
        10.8.3 BioMerieux SA Cardiac Biomarkers Sales, Revenue, Price and Gross Margin (2012-2017)
        10.8.4 Main Business/Business Overview
    10.9 Bio-Rad Laboratories
        10.9.1 Company Basic Information, Manufacturing Base and Competitors
        10.9.2 Cardiac Biomarkers Product Category, Application and Specification
            10.9.2.1 Product A
            10.9.2.2 Product B
        10.9.3 Bio-Rad Laboratories Cardiac Biomarkers Sales, Revenue, Price and Gross Margin (2012-2017)
        10.9.4 Main Business/Business Overview

11 Cardiac Biomarkers Manufacturing Cost Analysis
    11.1 Cardiac Biomarkers Key Raw Materials Analysis
        11.1.1 Key Raw Materials
        11.1.2 Price Trend of Key Raw Materials
        11.1.3 Key Suppliers of Raw Materials
        11.1.4 Market Concentration Rate of Raw Materials
    11.2 Proportion of Manufacturing Cost Structure
        11.2.1 Raw Materials
        11.2.2 Labor Cost
        11.2.3 Manufacturing Expenses
    11.3 Manufacturing Process Analysis of Cardiac Biomarkers

12 Industrial Chain, Sourcing Strategy and Downstream Buyers
    12.1 Cardiac Biomarkers Industrial Chain Analysis
    12.2 Upstream Raw Materials Sourcing
    12.3 Raw Materials Sources of Cardiac Biomarkers Major Manufacturers in 2016
    12.4 Downstream Buyers

13 Marketing Strategy Analysis, Distributors/Traders
    13.1 Marketing Channel
        13.1.1 Direct Marketing
        13.1.2 Indirect Marketing
        13.1.3 Marketing Channel Development Trend
    13.2 Market Positioning
        13.2.1 Pricing Strategy
        13.2.2 Brand Strategy
        13.2.3 Target Client
    13.3 Distributors/Traders List

14 Market Effect Factors Analysis
    14.1 Technology Progress/Risk
        14.1.1 Substitutes Threat
        14.1.2 Technology Progress in Related Industry
    14.2 Consumer Needs/Customer Preference Change
    14.3 Economic/Political Environmental Change

15 Asia-Pacific Cardiac Biomarkers Market Forecast (2017-2022)
    15.1 Asia-Pacific Cardiac Biomarkers Sales Volume, Revenue and Price Forecast (2017-2022)
        15.1.1 Asia-Pacific Cardiac Biomarkers Sales Volume and Growth Rate Forecast (2017-2022)
        15.1.2 Asia-Pacific Cardiac Biomarkers Revenue and Growth Rate Forecast (2017-2022)
        15.1.3 Asia-Pacific Cardiac Biomarkers Price and Trend Forecast (2017-2022)
    15.2 Asia-Pacific Cardiac Biomarkers Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
        15.2.1 Asia-Pacific Cardiac Biomarkers Sales Volume and Growth Rate Forecast by Region (2017-2022)
        15.2.2 Asia-Pacific Cardiac Biomarkers Revenue and Growth Rate Forecast by Region (2017-2022)
        15.2.3 China Cardiac Biomarkers Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.4 Japan Cardiac Biomarkers Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.5 South Korea Cardiac Biomarkers Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.6 Taiwan Cardiac Biomarkers Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.7 India Cardiac Biomarkers Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.8 Southeast Asia Cardiac Biomarkers Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.9 Australia Cardiac Biomarkers Sales, Revenue and Growth Rate Forecast (2017-2022)
    15.3 Asia-Pacific Cardiac Biomarkers Sales, Revenue and Price Forecast by Type (2017-2022)
        15.3.1 Asia-Pacific Cardiac Biomarkers Sales Forecast by Type (2017-2022)
        15.3.2 Asia-Pacific Cardiac Biomarkers Revenue Forecast by Type (2017-2022)
        15.3.3 Asia-Pacific Cardiac Biomarkers Price Forecast by Type (2017-2022)
    15.4 Asia-Pacific Cardiac Biomarkers Sales Forecast by Application (2017-2022)

16 Research Findings and Conclusion

17 Appendix
    17.1 Methodology/Research Approach
        17.1.1 Research Programs/Design
        17.1.2 Market Size Estimation
        17.1.3 Market Breakdown and Data Triangulation
    17.2 Data Source
        17.2.1 Secondary Sources
        17.2.2 Primary Sources
    17.3 Disclaimer